CORRESP Filing
PURPLE BIOTECH LTD.
Date: Aug. 29, 2025 · CIK: 0001614744 · Accession: 0001213900-25-082613
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289927
Letter
Purple Biotech Ltd.
4 Oppenheimer Street, Science Park
Rehovot 7670104, Israel
August 29, 2025
VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance
Office of Life Sciences
100 F Street N.E. Washington, D.C. 20549
Attention: Lauren Hamill
Re: Purple Biotech Ltd. Registration Statement on Form F-1
Filed August 29, 2025
File No. 333-289927 (the " Registration Statement ")
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Purple Biotech Ltd. (the " Company ") hereby respectfully requests that the effective date of the Company's Registration Statement be accelerated by the Securities and Exchange Commission to 9:00 a.m., Eastern Time on September 3, 2025, or as soon thereafter as practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to the Company's counsel, Haynes and Boone, LLP, by calling Jayun Koo at (212) 835-4823, and that such effectiveness also be confirmed in writing .
Very truly yours,
Purple Biotech Ltd.
Show Raw Text
CORRESP 1 filename1.htm Purple Biotech Ltd. 4 Oppenheimer Street, Science Park Rehovot 7670104, Israel August 29, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street N.E. Washington, D.C. 20549 Attention: Lauren Hamill Re: Purple Biotech Ltd. Registration Statement on Form F-1 Filed August 29, 2025 File No. 333-289927 (the " Registration Statement ") Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Purple Biotech Ltd. (the " Company ") hereby respectfully requests that the effective date of the Company's Registration Statement be accelerated by the Securities and Exchange Commission to 9:00 a.m., Eastern Time on September 3, 2025, or as soon thereafter as practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to the Company's counsel, Haynes and Boone, LLP, by calling Jayun Koo at (212) 835-4823, and that such effectiveness also be confirmed in writing . Very truly yours, Purple Biotech Ltd. By: /s/ Gil Efron Gil Efron Chief Executive Officer cc: Rick A. Werner, Esq., Haynes and Boone, LLP Jayun Koo, Esq., Haynes and Boone, LLP